Sprycel and Glucophage drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Sprycel (dasatinib) and Glucophage (metformin hydrochloride). Common drug interactions include general physical health deterioration among females and pleural effusion among males.

The phase IV clinical study analyzes what interactions people have when they take Sprycel and Glucophage. It is created by eHealthMe based on reports of 26 people who take the same drugs from the FDA, and is updated regularly.

What is Sprycel?

Sprycel has active ingredients of dasatinib. It is often used in chronic myelogenous leukemia (cml). eHealthMe is studying from 29,788 Sprycel users. Check the latest studies of Sprycel.

What is Glucophage?

Glucophage has active ingredients of metformin hydrochloride. It is often used in diabetes. eHealthMe is studying from 60,851 Glucophage users. Check the latest studies of Glucophage.



On Jul, 19, 2026

26 people who take Sprycel and Glucophage together, and have interactions are studied.

Sprycel and Glucophage drug interactions.

What are the common drug interactions of Sprycel and Glucophage, by gender? *:

female:

  1. General physical health deterioration (weak health status)
  2. Hepatitis acute
  3. Nausea (feeling of having an urge to vomit)
  4. Haematemesis (vomiting of blood)
  5. Costochondritis (chest wall pain)
  6. Increased tendency to bruise (increased tendency to injure the underlying soft tissue or bone)
  7. Pleurisy (inflammation of the pleurae, which causes pain when breathing)
  8. Red blood cell count decreased
  9. Abdominal discomfort
  10. Adverse event

male:

  1. Pleural effusion (water on the lungs)
  2. Renal cancer (cancer of kidney)
  3. Angiosarcoma metastatic (cancer of endothelial-type cells that line vessel walls-metastatic)
  4. Arthralgia (joint pain)
  5. Asthenia (weakness)
  6. Back pain
  7. Blood bilirubin increased
  8. Blood iron increased
  9. Bone marrow failure
  10. Bone pain

What are the common drug interactions of Sprycel and Glucophage, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Anaemia (lack of blood)
  2. Blood glucose increased
  3. Decreased appetite
  4. Disseminated intravascular coagulation (systemic activation of blood coagulation)
  5. Gastrointestinal mucosal disorder (disorder of gastrointestinal lining mucous membranes)
  6. Generalised oedema (swelling all over the body)
  7. Malignant neoplasm progression (cancer tumour came back)
  8. Neuropathy peripheral (surface nerve damage)
  9. Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
  10. Platelet count decreased

40-49:

  1. Costochondritis (chest wall pain)
  2. Increased tendency to bruise (increased tendency to injure the underlying soft tissue or bone)
  3. Pleurisy (inflammation of the pleurae, which causes pain when breathing)
  4. Red blood cell count decreased
  5. Abdominal discomfort

50-59:

  1. Cardiac disorder
  2. Fatigue (feeling of tiredness)
  3. Hypertension (high blood pressure)
  4. Nausea (feeling of having an urge to vomit)
  5. Posterior reversible encephalopathy syndrome (posterior reversible encephalopathy syndrome (pres), also known as reversible posterior leukoencephalopathy syndrome (rpls), is a syndrome characterized by headache, confusion, seizures and visual loss)

60+:

  1. General physical health deterioration (weak health status)
  2. Hepatitis acute
  3. Anaemia (lack of blood)
  4. Angina pectoris (chest pain due to ischemia of the heart muscle)
  5. Angiosarcoma metastatic (cancer of endothelial-type cells that line vessel walls-metastatic)
  6. Arthralgia (joint pain)
  7. Back pain
  8. Blood bilirubin increased
  9. Blood iron increased
  10. Bone marrow failure

What are the existing conditions these people have? *

  1. Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 14 people, 53.85%
  2. Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 10 people, 38.46%
  3. Type 2 Diabetes: 2 people, 7.69%
  4. Stress And Anxiety: 2 people, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Sprycel and Glucophage?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Sprycel and Glucophage:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Sprycel:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Glucophage:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Sprycel and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Glucophage and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on dasatinib and metformin hydrochloride (the active ingredients of Sprycel and Glucophage, respectively), and Sprycel and Glucophage (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: